In 1943, a chemist in Switzerland synthesized a drug that alters consciousness. His discovery changed the study of medicine, ...

Trump signed an executive order Saturday to ease research restrictions on psychedelic drugs like psilocybin and LSD, aiming ...

Military veterans may eventually see newer forms of mental health relief by way of treatments being greenlighted by the ...

The president’s executive order is intended to accelerate research into the compounds’ efficacy in treating mental health ...

Drug trials generally involve comparing a treatment with a nonactive, placebo version, an approach called "blinding" because ...

Polaryx Therapeutics, Inc. (Nasdaq: PLYX), a clinical-stage biotechnology company developing disease-modifying therapies for rare pediatric LSDs, today announced that the U.S. Food and Drug ...

President Donald Trump announced new efforts to boost research into psychedelic drugs and make them available in controlled ...

Surging interest in the purported benefits of psychedelic drugs has given rise to a new industry: psychedelic retreats.

A new policy shift could open the door to clinical use of drugs like psilocybin and MDMA, but legal and safety questions ...

Kennedy, Jr. Meanwhile, plenty of people aren’t waiting for government approval before experimenting: About 8 million US ...

Founders of the Integrative Psychiatry Institute, Dr. Will Van Derveer and Keith Kurlander, discuss their new book, ...

The administration is taking steps to ease restrictions and spur research on using the drugs for medical purposes, including ...